SS

Shobhanaben Sapan Shah

Active Director Director DIN 07933020
DIN 07933020 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Shobhanaben Sapan Shah

Data last updated:

Shobhanaben Sapan Shah is a Director at Krayon Lifesciences India Private Limited (since 2017). The company operates in Pharma. Krayon Lifesciences India Private Limited reported revenue of ₹82.7 Lakh (FY 2022).

DIN 07933020
Primary Designation Director
Industry Pharma
First Appointment 08 Dec 2017
Oldest Company Age 8 yrs
Largest company Krayon Lifesciences India Private Limited · ₹82.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Dec 20172017₹82.7 Lakh (FY 2022)Active

Board colleagues of Shobhanaben Sapan Shah

Directorship timeline

Open interactive timeline →
Krayon Lifesciences India Private Limited
Premium access

Shareholding and investment profile for Shobhanaben Sapan Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shobhanaben Sapan Shah

Shobhanaben Sapan Shah currently holds 1 directorship: Krayon Lifesciences India Private Limited (Director, since 08 Dec 2017, revenue ₹82.7 Lakh (FY 2022)).

Shobhanaben Sapan Shah was first appointed on 08 Dec 2017 as Director at Krayon Lifesciences India Private Limited.

The current boards of Shobhanaben Sapan Shah's companies include Sapan Mukeshbhai Shah (Krayon Lifesciences India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available